Arbeitspapier

Genetic testing and repulsion from chance

A central theme in the international debate on genetic testing concerns the extent to which insurance companies should be allowed to use genetic information in their design of insurance contracts. We analyze this issue within a model with the following important feature: A person’s well-being depends on the perceived probability of becoming ill in the future in a way that varies among individuals. We show that both tested high-risks and untested individuals are equally well off whether or not test results can be used by insurers. Individuals who test for being low-risks, on the other hand, are made worse off by not being able to verify this to insurers. This implies that verifiability dominates nonverifiability in an ex-ante sense.

Sprache
Englisch

Erschienen in
Series: Memorandum ; No. 2003,20

Klassifikation
Wirtschaft
Asymmetric and Private Information; Mechanism Design
Analysis of Health Care Markets
Health: Government Policy; Regulation; Public Health
Thema
Genetic testing
asymmetric information
insurance
Gentechnik
Gesetzliche Krankenversicherung
Private Krankenversicherung
Asymmetrische Information
Theorie

Ereignis
Geistige Schöpfung
(wer)
Hoel, Michael
Iversen, Tor
Nilssen, Tore
Vislie, Jon
Ereignis
Veröffentlichung
(wer)
University of Oslo, Department of Economics
(wo)
Oslo
(wann)
2003

Handle
Letzte Aktualisierung
10.03.2025, 11:41 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Objekttyp

  • Arbeitspapier

Beteiligte

  • Hoel, Michael
  • Iversen, Tor
  • Nilssen, Tore
  • Vislie, Jon
  • University of Oslo, Department of Economics

Entstanden

  • 2003

Ähnliche Objekte (12)